Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human GPR37L1 ELISA Kit (AC2674)
Cat.#: ASET-1263
Specifications
Description Human GPR37L1 ELISA Kit allows for the in vitro quantitative determination of human GPR37L1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1868 Human CASK ELISA Kit (AC3279) Quantitative inquiry ASET-2186 Human Calretinin ELISA Kit (AC3597) Quantitative inquiry ASET-1796 Human iNOS ELISA Kit (AC3207) Quantitative inquiry ASET-1998 Human Vaspin ELISA Kit (AC3409) Quantitative inquiry ASET-1859 Human G-Protein Coupled Receptor 30 ELISA Kit (AC3270) Quantitative inquiry ASET-2483 Human Iba1 ELISA Kit (AC3894) Quantitative inquiry ASET-1182 Human CDK5 ELISA Kit (AC2593) Quantitative inquiry ASET-1752 Human Otx2 ELISA Kit (AC3163) Quantitative inquiry ASET-1902 Human Apolipoprotein E ELISA Kit (AC3313) Quantitative inquiry ASET-2047 Mouse CaSR ELISA Kit (AC3458) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket